Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)
Topiramate Tablet
Product Images NDC 63187-963
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 63187-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)
The text is describing a graph that shows cumulative rates over time. The values on the y-axis range from 0 to 0.30, with intervals of 0.05. The x-axis ranges from 0 to 450, with intervals of 50. There is a significant difference indicated by the probability value (p=0.0002). However, there is not enough context to determine what this graph is specifically referring to.*
Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)
63187-963-30 (6491d395 Ef69 4db7 Abe1 87f061db14d8 07)
This is a prescription drug called Topiramate 200mg, packed in a bottle of #30 tablets by ProficientRx LP. Each pink-colored film-coated tablet is capsule-shaped, debossed with "125" on one side and "Cipla" on the other side. The drug is manufactured by Cipla Ltd. in India, and the bottle has a Lot No. 00000 and an expiration date of 00/00/00. It is important to store the medication between 20°-25°C (68°-77°F) and keep it out of the reach of children. The National Drug Code (NDC) is 63187-963-30. Each patient should be given a medication guide.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
